Skip to main content

Advanced OCT System Integral to Eye Transplantation






An adaptation of OCT put into use at Northwestern University, visible OCT (vis-OCT), will be a key component in an Advanced Research Projects Agency for Health (ARPA-H)-funded project that aims to conduct successful eye transplants in the next several years. The technology will be used to examine the structural integrity of eyes in donors, such as the health of retinal layers and the flow of blood as well as monitoring their continued viability throughout the process.

This work will be supported by over $50 million in ARPA-H funds to multiple institutions, earmarked for viability, imaging, surgical, immunomodulation, ocular preservation, and neuroregeneration strategies within the Transplantation of Human Eye Allografts (THEA) project. The Northwestern team, led by Hao Zhang, a professor of biomedical engineering, and Cheng Sun, a professor of mechanical engineering, will be part of group directed by Jeffrey Goldberg, professor and chair of ophthalmology at the Byers Eye Institute at Stanford University.

Opticent Health, a spinoff company of Zhang’s lab at Northwestern, created the Halo 375 for animal research and the Aurora X4 for human research. These center on a vis-OCT system that includes a supercontinuum white light laser based on photonic crystals, fundus camera for fast imaging, an adjustable field of view, and software to analyze the generated data. It has not yet been approved by the FDA, but is in use for clinical research.

“At this point, we have created the system, it is about overcoming logistical issues associated with this project,” Zhang said. “We have to adapt it for a robotic arm and account for multiple instruments at the bedside. A traditional OCT instrument is used with a chin rest when the patient is sitting, but obviously that wouldn’t work for something like this.”

He said the ARPA-H funding includes expectations of meeting certain guidelines, such as a system ready for use in a medical setting within the next two years, and a clinical protocol within the next three years.

Eye transplants are not new, as more than 70,000 people in the U.S. donate their eyes each year when they die. But these historically have involved corneal transplants, whereas the most common forms of vision loss are caused by retinal degeneration. That is where the whole-eye transplants fit into global eye health. And Zhang acknowledged the questions that need to be answered go beyond the imaging itself.

“With a whole-eye transplant you would need to look at how the muscles attach and whether the blood will flow as it should,” he said. “Then there’s the question of attaching and regenerating the nerves. But I know there are lots of people working on that part of the problem, too.”


Bio Photonics Research Award


Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee

#MeatAnalysis #FluorescenceTech #FoodQuality #FoodSafety #SpectroscopyInFood #MeatAuthentication #RapidDetection #FoodScience #MeatFreshness #MolecularDetection #FoodIndustryInnovation #NonDestructiveTesting #FoodMonitoring #SpectroscopyApplications #QualityControl #AdvancedSpectroscopy #MeatSpoilageDetection #FoodIntegrity #SmartFoodTesting #RealTimeAnalysis #FoodAuthenticity #FoodSafetyInnovation #SpectroscopyResearch #NextGenFoodSafety #InnovativeFoodScience,

Comments

Popular posts from this blog

Abrisa Technologies Acquires Agama Glass Technologies

SANTA PAULA, Calif. — Abrisa Technologies, a provider of custom glass optics and thin film coatings and a subsidiary of HEF Photonics, has acquired Agama Glass Technologies, a manufacturer of etched anti-glare glass and technical glass processing. The acquisition, Abrisa said, expands its manufacturing footprint and adds a vertically integrated solution for chemically etched anti-glare display glass. According to Abrisa, Clarksburg, West Virginia-based Agama operates North America’s only high-volume technical glass etching facility. Agama's flagship product, AgamaEtch, is used in high-performance display and optics applications. The company's 85,000 sq ft facility also offers precision glass fabrication, chemical strengthening, and silk-screen printing, serving markets such as avionics, defense, medical, industrial, and touchscreen displays. Combined with Abrisa Technologies’ and HEF Photonics’ thin-film coating and surface engineering capabilities, Agama's offerings wi...

How Biophotonics Is Harnessing Light for Health And Science

Fifty or so years ago French physicist Pierre Aigrain coined the term photonics as a research field whose goal was to use light to perform functions that traditionally fell within the typical domain of electronics, such as telecommunications, and information processing. Or maybe it was John Campbell who, in a letter sent to Gotthard Gunther in 1954, wrote, “Incidentally, I’ve decided to invent a new science — photonics. It bears the same relationship to Optics that electronics does to electrical engineering. Photonics, like electronics, will deal with the individual units; optics and EE deal with the group phenomena! And note that you can do things with electronics that are impossible in electrical engineering!” Naming rights aside, the field of photonics began in earnest between 1958 and 1960 with the invention of the maser and the laser. The laser diode followed during the 1970s, optical fibers and the erbium-doped fiber amplifier after that, and, pretty soon, the telecommunications...

Laser Method Enables Fast & Precise Blood Vessels in Hydrogel

Researchers from Vienna University of Technology (TU Wien) and Keio University have found a way to create artificial blood vessels in miniature organ models in a quick and reproducible manner. The method utilizes ultrashort laser pulses in the femtosecond range to write highly 3D structures into a hydrogel. In biomedical research, organs-on-a-chip are becoming increasingly important: By cultivating tissue structures in precisely controlled microfluidic chips, it is possible to conduct research much more accurately than in experiments involving living humans or animals. However, there has been a major obstacle: such mini-organs are incomplete without blood vessels. To facilitate systematic studies and ensure meaningful comparisons with living organisms, a network of perfusable blood vessels and capillaries must be created — in a way that is precisely controllable and reproducible. “We can create channels spaced only a hundred micrometers apart. That’s essential when you would like to...